Suvorexant beneficial for VMS-associated insomnia in midlife women
13 Oct 2020
bởiAudrey Abella
The dual orexin receptor antagonist suvorexant was effective in managing VMS*-associated insomnia among women in midlife, with further benefits for self-reported night-time, but not daytime, VMS, according to data presented at NAMS 2020.